Infinium Pharmachem Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company has delivered good profit growth of 52.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.6%
- Company has a healthy return on capital (ROCE) of 26.5%
- Company has delivered good sales growth of 30.6% CAGR over last 5 years
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.54x)
- Total debt has risen sharply - up 471.1% year on year
- Working capital days have increased from 136 to 193 days
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 22307.50 | 101.37 | 201860.69 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1567.45 | 60.23 | 159547.55 | 1.37 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2483.00 | 34.05 | 73602.28 | 0.36 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4771.75 | 85.23 | 52417.67 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8541.10 | 55.49 | 43822.77 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1127.00 | 32.29 | 37963.11 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| AETHER | 1672.95 | 94.41 | 22204.70 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| DEEPAKNTR | 1587.10 | 27.64 | 21646.94 | 0.47 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| ATUL | 6244.55 | 23.11 | 18385.05 | 0.48 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 492.15 | 33.62 | 17851.59 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1320.45 | 17.00 | 16725.20 | 0.76 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| INFINIUM | 266.20 | 34.14 | 414.82 | 0.00 | — | — | — | — | 13.23 | — |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
No standalone quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 36 | 55 | 74 | 101 | 122 | 137 | |
| 33 | 50 | 65 | 86 | 105 | 122 | |
| Operating Profit | 3 | 5 | 9 | 15 | 17 | 15 |
| OPM % | 7.28% | 9.00% | 11.78% | 15.01% | 14.23% | 11.09% |
| 1 | 1 | 1 | 1 | 2 | 2 | |
| Interest | 1 | 1 | 2 | 3 | 2 | 3 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 3 |
| Profit before Tax | 1 | 4 | 7 | 12 | 15 | 12 |
| Tax % | 26.70% | 27.65% | 25.68% | 25.40% | 25.35% | 27.03% |
| Net Profit | 1 | 3 | 6 | 9 | 11 | 8 |
| EPS | 10.01 | 26.75 | 54.13 | 18.00 | 7.97 | 5.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 31%
- 3 Years:
- 23%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 53%
- 3 Years:
- 15%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 2%
- 1 Year:
- 4%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 39%
- 3 Years:
- 31%
- Last Year:
- 10%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 14 | 16 |
| 3 | 6 | 12 | 17 | 44 | 90 | |
| 9 | 11 | 22 | 26 | 8 | 39 | |
| Trade Payables | 6 | 11 | 10 | 9 | 8 | 11 |
| 1 | 2 | 4 | 4 | 5 | 11 | |
| Total Liabilities | 21 | 31 | 49 | 60 | 78 | 166 |
| 4 | 4 | 4 | 16 | 16 | 17 | |
| Capital Work in Progress | 0 | 4 | 8 | 0 | 0 | 1 |
| 0 | 0 | 0 | 0 | 0 | 16 | |
| 7 | 9 | 14 | 18 | 22 | 35 | |
| 0 | 0 | 0 | 0 | 24 | 34 | |
| Cash & Bank | 0 | 1 | 2 | 3 | 8 | 33 |
| 9 | 12 | 21 | 23 | 6 | 30 | |
| Total Assets | 21 | 31 | 49 | 60 | 78 | 166 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 3 | 8 | 11 | 10 | 3 | -26 | |
| Cash from Investing | -1 | -5 | -7 | -3 | -3 | -23 |
| Cash from Financing | -1 | -1 | -2 | -3 | 5 | 74 |
| 0 | 1 | 0 | 2 | 5 | 25 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for INFINIUM
Loading news…
AI Stock Analyst
Infinium Pharmachem Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account